Skip to main content
Top
Published in: BMC Gastroenterology 1/2023

Open Access 01-12-2023 | Hepatitis B | Research

Trend analysis of hepatitis B and C among patients visiting health facility of Tigrai, Ethiopia, 2014–2019

Authors: Haftom Legese, Brhane Berhe, Gebre Adhanom, Tsega Kahsay, Aderajew Gebrewahd, Guesh Gebremariam, Fitsum Mardu, Kebede Tesfay, Haftay Gebremedhin, Hadush Negash

Published in: BMC Gastroenterology | Issue 1/2023

Login to get access

Abstract

Background

Hepatitis B and C viruses are the major public health concerns of the globe. The two hepatotropic viruses share common modes of transmission and their co-infection is common. Despite the provision of an effective prevention mechanism, the infections caused by these viruses remain a significant problem worldwide, particularly among developing countries like Ethiopia.

Methods

This institutional-based retrospective study was conducted between January 2014 December and December 2019 from documented laboratory logbooks of Adigrat general hospital serology laboratory, Tigrai, Ethiopia. data were collected and checked for completeness on a daily based, coded, entered, and cleaned using Epinfo version 7.1, exported and analyzed using SPSS version 23. Binary logistic regression analysis and Chi-square test (X2) assessed the association between dependent and independent variables. The corresponding variables with a P-value (P < 0.05) and 95% confidence interval were considered statistically significant.

Results

Out of 20,935 clinically suspected individuals, 20,622 were given specimens and tested for hepatitis B and C viruses with total completeness of 98.5%. The overall prevalence of hepatitis B and hepatitis C virus was found to be 3.57% (689/19,273) and 2.13% (30/1,405), respectively. The positivity rate of the hepatitis B virus was 8.0% (106/1317) and 3.24% (583/17,956) among males and females, respectively. Additionally, 2.49%( 12/481) of males and 1.94% (18/924) of females were positive for hepatitis C virus infection. The overall prevalence of co-infection for both hepatitis B and hepatitis C virus was 7.4% (4/54). Sex and age were significantly associated with hepatitis B and C virus infection.

Conclusions

The overall prevalence of hepatitis B and C is low intermediate according to the WHO criteria. Although there was a fluctuating trend of hepatitis B and C through the years 2014–2019, the result shows moreover declining trend. Both hepatitis B and C share similar routes of transmission and affect all age categories but males were more highly affected than females. Therefore, awareness creation of the community about the methods of transmission, education about prevention, and control of hepatitis B and C virus infection, and improving coverage of youth-friendly services in health facilities should be strengthened.
Literature
3.
go back to reference Lanini S, Pisapia R,Capobianchi MRG. Global epidemiology of viral hepatitis and national needs for complete control. Expert Rev Anti-Infect Ther. 2018;I(8):625–39.CrossRef Lanini S, Pisapia R,Capobianchi MRG. Global epidemiology of viral hepatitis and national needs for complete control. Expert Rev Anti-Infect Ther. 2018;I(8):625–39.CrossRef
5.
go back to reference Hofstraat SH, Falla AM,Duffell EF, Hahne SJ, Amato-Gauci AJVeldhuijzen. IK ea: current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU/EEA: a systematic review. Epidemiol Infect. 2017;145(14):2873–85.CrossRefPubMedPubMedCentral Hofstraat SH, Falla AM,Duffell EF, Hahne SJ, Amato-Gauci AJVeldhuijzen. IK ea: current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU/EEA: a systematic review. Epidemiol Infect. 2017;145(14):2873–85.CrossRefPubMedPubMedCentral
7.
go back to reference Global Hepatitis Report. 2017. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO. In. Global Hepatitis Report. 2017. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO. In.
9.
go back to reference Foster GR. Pegylated interferons for the treatment of chronic hepatitis C: pharmacological and clinical differences between peginterferon-alpha-2a and peginterferon-alpha-2b. Drugs. 2010;70(2):147–65.CrossRefPubMed Foster GR. Pegylated interferons for the treatment of chronic hepatitis C: pharmacological and clinical differences between peginterferon-alpha-2a and peginterferon-alpha-2b. Drugs. 2010;70(2):147–65.CrossRefPubMed
10.
go back to reference Turati F, Edefonti V, Talamini R,Ferraroni MMalvezziM, Bravi F, et al. Family history of liver cancer and hepatocellular carcinoma. Hepatology. 2012;55(5):1416–25.CrossRefPubMed Turati F, Edefonti V, Talamini R,Ferraroni MMalvezziM, Bravi F, et al. Family history of liver cancer and hepatocellular carcinoma. Hepatology. 2012;55(5):1416–25.CrossRefPubMed
11.
go back to reference Andre F. Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine 2000, 18(1):S20–2. Andre F. Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine 2000, 18(1):S20–2.
12.
go back to reference WHO. Protocol for assessing prevalence of Hepatitis B infection in antenatal patients. Geneva: World Health Organization; 1990. WHO. Protocol for assessing prevalence of Hepatitis B infection in antenatal patients. Geneva: World Health Organization; 1990.
16.
go back to reference Riou J, Aït Ahmed M, Blake A, Vozlinsky S, Brichler S,Eholié S et al. Hepatitis C virus seroprevalence in adults in Africa: a systematic review and meta-analysis. Journal of viral hepatitis 2016, 23(4):244-255.10.1111/jvh.12481. Riou J, Aït Ahmed M, Blake A, Vozlinsky S, Brichler S,Eholié S et al. Hepatitis C virus seroprevalence in adults in Africa: a systematic review and meta-analysis. Journal of viral hepatitis 2016, 23(4):244-255.10.1111/jvh.12481.
17.
go back to reference World Health Organization. Hepatitis B vaccines. Wkly Epidemiol Re. 2004;79:255–63. World Health Organization. Hepatitis B vaccines. Wkly Epidemiol Re. 2004;79:255–63.
18.
go back to reference UNICEF and WHO. Progress on Sanitation and Drinking Water- update and MDG assessment.2015. UNICEF and WHO. Progress on Sanitation and Drinking Water- update and MDG assessment.2015.
19.
go back to reference Tesfa H, Biadgo B, Getachew F, Tegegne K. Seroprevalence of hepatitis B and C virus infection among patients attending serology laboratory of Gondar University Hospital. BMC Res Notes. 2013;6:164.CrossRefPubMedPubMedCentral Tesfa H, Biadgo B, Getachew F, Tegegne K. Seroprevalence of hepatitis B and C virus infection among patients attending serology laboratory of Gondar University Hospital. BMC Res Notes. 2013;6:164.CrossRefPubMedPubMedCentral
20.
go back to reference Population. : City population Adigrat. Adigrat City municipality 2013. Population. : City population Adigrat. Adigrat City municipality 2013.
21.
go back to reference Perz JF, Armstrong GL, Farrington LA,Hutin YJBP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006;45:529–38.CrossRefPubMed Perz JF, Armstrong GL, Farrington LA,Hutin YJBP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006;45:529–38.CrossRefPubMed
22.
go back to reference Kit hwlcfHCT. : [Last accessed on 2023 April 19]. Kit hwlcfHCT. : [Last accessed on 2023 April 19].
24.
go back to reference World Health Organization. Global policy on the prevention andcontrol of viral hepatitis [In portuguese]. Ministry of Health, Organization; 2014. World Health Organization. Global policy on the prevention andcontrol of viral hepatitis [In portuguese]. Ministry of Health, Organization; 2014.
25.
go back to reference Taye M, Daka DAmsaluA, Hussen S. Magnitude of hepatitis B and C virus infections and associated factors among patients scheduled for surgery at Hawassa University comprehensive specialized hospital, Hawassa City, Southern Ethiopia. Res Notes. 2019;12(412). https://doi.org/10.1186/s13104-019-4456-0. Taye M, Daka DAmsaluA, Hussen S. Magnitude of hepatitis B and C virus infections and associated factors among patients scheduled for surgery at Hawassa University comprehensive specialized hospital, Hawassa City, Southern Ethiopia. Res Notes. 2019;12(412). https://​doi.​org/​10.​1186/​s13104-019-4456-0.
26.
go back to reference Lokpo SY, Osei-Yeboah J, Norgbe GK, Owiafe PK, Ayroe F, Ussher FA, et al. Viral Hepatitis Endemicity and Trends among an Asymptomatic Adult Population in Ho: a 5-Year retrospective study at the Ho Municipal Hospital, Ghana. Hepat Res and Treatment. 2017;2017. https://doi.org/10.1155/2017/6174743. Lokpo SY, Osei-Yeboah J, Norgbe GK, Owiafe PK, Ayroe F, Ussher FA, et al. Viral Hepatitis Endemicity and Trends among an Asymptomatic Adult Population in Ho: a 5-Year retrospective study at the Ho Municipal Hospital, Ghana. Hepat Res and Treatment. 2017;2017. https://​doi.​org/​10.​1155/​2017/​6174743.
27.
go back to reference Omote VKashibuE, Ojumah I,Adda D. Serological screening of hepatitis B virus and hepatitis C virus among patients attending a tertiary hospital in Jalingo, Taraba state, Nigeria. Saudi J Health Sci. 2018;7:167–71.CrossRef Omote VKashibuE, Ojumah I,Adda D. Serological screening of hepatitis B virus and hepatitis C virus among patients attending a tertiary hospital in Jalingo, Taraba state, Nigeria. Saudi J Health Sci. 2018;7:167–71.CrossRef
28.
go back to reference Darwish MA, Khalil AH,Yassin MMAwad IF. Prevalence of hepatitis C virus and hepatitis B virus antibodies among intravenous drug addicts and the associated risk factors - ain Shams University. Egypt. J Med Lab Sci (ESIC) 2005, 14(2) Darwish MA, Khalil AH,Yassin MMAwad IF. Prevalence of hepatitis C virus and hepatitis B virus antibodies among intravenous drug addicts and the associated risk factors - ain Shams University. Egypt. J Med Lab Sci (ESIC) 2005, 14(2)
29.
go back to reference Sajjadi SM, Pourfathollah AA,Mohammadi S, Nouri B: The Prevalence and Trends of Hepatitis B, Hepatitis C. and HIV among Voluntary Blood Donors in Kohgiluyeh and Boyer-Ahmad Transfusion Center, Southwestern Iran Iran J Public Health 2018, 47(7):944–951.Available at: http://ijph.tums.ac.ir. Sajjadi SM, Pourfathollah AA,Mohammadi S, Nouri B: The Prevalence and Trends of Hepatitis B, Hepatitis C. and HIV among Voluntary Blood Donors in Kohgiluyeh and Boyer-Ahmad Transfusion Center, Southwestern Iran Iran J Public Health 2018, 47(7):944–951.Available at: http://​ijph.​tums.​ac.​ir.
30.
go back to reference Pennap GR, Aliyu Y, Odula OJoseph F. Prevalence of hepatitis B and C virus infection among people of a local community in Keffi, Nigeria. Afr J Microbiol Resour Announc. 2010;4:274–8. Pennap GR, Aliyu Y, Odula OJoseph F. Prevalence of hepatitis B and C virus infection among people of a local community in Keffi, Nigeria. Afr J Microbiol Resour Announc. 2010;4:274–8.
31.
go back to reference Marcon CEM, Schneider IJC, Schuelter-Trevisol Fand Traebert J. Trends in the Burden of Hepatitis B in a southern brazilian state. Hepat Mon. 2015;15(11):e31906.CrossRefPubMedPubMedCentral Marcon CEM, Schneider IJC, Schuelter-Trevisol Fand Traebert J. Trends in the Burden of Hepatitis B in a southern brazilian state. Hepat Mon. 2015;15(11):e31906.CrossRefPubMedPubMedCentral
32.
go back to reference Ahmed W, Qureshi H, Arif AEjaz Alam S. Changing trend of viral hepatitis -“A twenty one year report from Pakistan Medical Research Council Research Centre, Jinnah Postgraduate Medical Centre, Karachi JPMA 2010, 60(86) Ahmed W, Qureshi H, Arif AEjaz Alam S. Changing trend of viral hepatitis -“A twenty one year report from Pakistan Medical Research Council Research Centre, Jinnah Postgraduate Medical Centre, Karachi JPMA 2010, 60(86)
33.
go back to reference Alomatu H. HIV, HBV, HCV and Syphilis Infections among Blood Donors in Koforidua, Ghana University of Ghana 2016, Ghana. Alomatu H. HIV, HBV, HCV and Syphilis Infections among Blood Donors in Koforidua, Ghana University of Ghana 2016, Ghana.
34.
go back to reference Walana W, Ahiaba SHokey P. Sero-prevalence of HIV, HBV and HCV among Blood Donors in the Kintampo Municipal Hospital, Ghana. Br Microbiol Res J. 2014;4(12):1491–9.CrossRef Walana W, Ahiaba SHokey P. Sero-prevalence of HIV, HBV and HCV among Blood Donors in the Kintampo Municipal Hospital, Ghana. Br Microbiol Res J. 2014;4(12):1491–9.CrossRef
Metadata
Title
Trend analysis of hepatitis B and C among patients visiting health facility of Tigrai, Ethiopia, 2014–2019
Authors
Haftom Legese
Brhane Berhe
Gebre Adhanom
Tsega Kahsay
Aderajew Gebrewahd
Guesh Gebremariam
Fitsum Mardu
Kebede Tesfay
Haftay Gebremedhin
Hadush Negash
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2023
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-023-02807-2

Other articles of this Issue 1/2023

BMC Gastroenterology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.